NCT02420132View on ClinicalTrials.gov

Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®)

CompletedOBSERVATIONAL
Enrollment

47

Participants

Timeline

Start Date

April 20, 2015

Primary Completion Date

August 25, 2016

Study Completion Date

August 25, 2016

Conditions
Macular EdemaMacular Degeneration
Interventions
OTHER

Ranibizumab

Ranibizumab administered as part of standard-of-care

Trial Locations (1)

84107

Rocky Mountain Retina, Salt Lake City

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02420132 - Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®) | Biotech Hunter | Biotech Hunter